Among 133 subjects undergoing VCTE, NOD participants (n = 26) had a significantly higher median (interquartile range) LSM of 9.1 kPa (6.3, 15.8) versus NL (n = 72, 5.1 kPa [4.2, 7.0]; P < 0.0001), HMG (n = 17, 5.9 kPa [5.2, 7.8]; P = 0.0013), and HTG (n = 18, 6.1 kPa [4.7, 7.0]; P = 0.0008) participants. HMG participants (n = 14) had a significantly higher mean CAP (SD) (270.5 dB/m [61.1]) compared with NL (n = 40, 218.8 dB/m [46.5]; P = 0.0027), HTG (n = 10, 218.1 dB/m [60.7]; P = 0.044), and NOD (n = 15, 222.7 dB/m [56.4]; P = 0.041) participants. LSM had a negative correlation with platelet count (r(s) = - 0.28, P = 0.0071) and positive correlation with aspartate aminotransferase-to-platelet ratio index (r(s) = 0.38, P = 0.0002), Fibrosis-4 index (r(s) = 0.36, P = 0.0007), gamma-glutamyltransferase (GGT; r(s) = 0.35, P = 0.0017), GGT-to-platelet ratio (r(s) = 0.35, P = 0.003), and US spleen size z-score (r(s) = 0.27, P = 0.0073).